Condition
Speech Disorder
Total Trials
6
Recruiting
2
Active
2
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed4
Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07264036Not ApplicableRecruiting
Velopharyngeal Dysfunction in Head & Neck Cancer Patients, Pilot Study
NCT07330687Not ApplicableCompleted
Neural Changes After Speech Therapy in Patients With Cleft Palate: A Brain Imaging Study
NCT06874322Not ApplicableRecruiting
Voiceitt for People With Impairments in Speech
NCT06633874Not ApplicableCompleted
Smart Computing Models, Sensors, and Early Diagnostic Speech and Language Deficiencies Indicators in Child Communication
NCT00001551Completed
Characteristics of Idiopathic Familial Speech Disorders
NCT00001167Completed
Ultrasound Evaluation of Tongue Movements in Speech and Swallowing
Showing all 6 trials